✦ LIBER ✦

Very late relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation

✍ Scribed by Arunabh Sekhri; Delong Liu; Muhammad Rasul; Nasir Ahmed; Tauseef Ahmed; Karen Seiter

Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 99 KB
Volume: 33
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2009.03.010

No coin nor oath required. For personal study only.

✦ Synopsis

Allogeneic stem cell transplantation is considered to be a curative treatment modality in patients with chronic myelogenous leukemia. However patients are at risk for relapse years after transplantation. Currently we present two patients who relapsed 16 and 24 years after allogeneic bone marrow transplantation, respectively. These patients emphasize the need for long term follow-up of such patients.

📜 SIMILAR VOLUMES

Porphyria cutanea tarda after allogeneic

Porphyria cutanea tarda after allogeneic bone marrow transplantation for chronic myelogenous leukemia

✍ Dr. D. Guyotat; J. F. Nicolas; F. Augey; D. Fiere; J. Thivolet 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB 👁 2 views

A case of porphyria cutanea terda (PCT) occurring after bone marrow transplantation (BMT) is reported. A 43-year-oid male with chronic myelogenous leukemia received an human leukocyte antigen (HLA)-identical allogeneic transplantation with T-cell depleted marrow. Because of graft rejection, a second

Juvenile chronic myelogenous leukemia: I

Juvenile chronic myelogenous leukemia: In vitro characterization before and after allogeneic bone marrow transplantation

✍ Zecca, Marco ;Rosti, Vittorio ;Pinto, Luciano ;Comoli, Patrizia ;Carrà, Anna Mar 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 465 KB

## Abstract In previously published studies on patients with juvenile chronic myelogenous leukemia (JCML), excessive proliferation of malignant monocyte‐macrophage elements and impaired growth of normal hematopoietic progenitors were demonstrated. A selective hypersentivity of granulocytemachrophag

Improved survival of patients with chron

Improved survival of patients with chronic myelogenous leukemia undergoing allogeneic bone marrow transplantation

✍ Jan Moreb; Thomas Johnson; Paul Kubilis; Lesley Myers; David Oblon; Alan Miller; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB 👁 2 views

Extra-medullary relapse of leukemia foll

Extra-medullary relapse of leukemia following allogeneic bone marrow transplantation

✍ W. Y. Au; Y. L. Kwong; A. K. W. Lie; S. K. Ma; R. Liang 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB 👁 2 views

The curative effect of allogeneic bone marrow transplantation (BMT) for acute and chronic leukemia is attributed to the intensive conditioning chemotherapy with or without radiotherapy, as well as an immune-mediated graft versus leukemia (GVL) effect. A different pattern of relapse has been observed

Treatment of hematological malignancies

Treatment of hematological malignancies relapsing after allogeneic bone marrow transplantation

✍ J.-M. Boiren; P. Cony-Makhoul; A. Pigneux; M. Puntous; J. Reiffers; J.-M. Boiron 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 903 KB

Splenic irradiation prior to high dose c

Splenic irradiation prior to high dose chemotherapy and allogeneic bone marrow transplantation for chronic myelogenous leukemia

✍ Joseph Ravalese III; Hywel Madoc-Jones; Marilyn Ling; David Schenkein; John Erba 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 79 KB